Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.

Also called NCT07389460

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 820 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07389460
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07389460. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-07 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
Condition
Acute Ischemic Stroke
Intervention (Drug)
Intravenous rhPro-UK
Intervention (Drug)
Intravenous placebo
Intervention (Procedure)
Endovascular thrombectomy
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University (class: other)
Collaborator
Tasly Pharmaceutical Group Co., Ltd (class: industry)
Collaborator
Peking Union Medical College Hospital (class: other)

Record details

Record id
cardio:ct-nct07389460
Content hash
bb3c9cfbb838942bfba58eafe9716a81a0d748ec16b1dd1c7b69b65d008d126f